These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 9536423
21. [A photoallergenicity study of prulifloxacin (NM441) in guinea pigs]. Kamata K, Ogawa A, Inoue T, Ishihara M, Ishimura K, Sumi N, Asaoka H, Shindo Y. J Toxicol Sci; 1996 Jun; 21 Suppl 1():259-65. PubMed ID: 8709166 [Abstract] [Full Text] [Related]
22. The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing. Begg EJ, Robson RA, Saunders DA, Graham GG, Buttimore RC, Neill AM, Town GI. Br J Clin Pharmacol; 2000 Jan; 49(1):32-8. PubMed ID: 10606835 [Abstract] [Full Text] [Related]
24. Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia. Marklein G. Chemotherapy; 1996 Mar; 42 Suppl 1():33-42. PubMed ID: 8861533 [Abstract] [Full Text] [Related]
25. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones. Blum RA. Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065 [Abstract] [Full Text] [Related]
26. Intestinal elimination of sparfloxacin, fleroxacin, and ciprofloxacin in rats. Rubinstein E, Dautrey S, Farinoti R, St Julien L, Ramon J, Carbon C. Antimicrob Agents Chemother; 1995 Jan 06; 39(1):99-102. PubMed ID: 7695338 [Abstract] [Full Text] [Related]
27. Efficacy and safety of single oral dose sparfloxacin vs ciprofloxacin in acute gonococcal urethritis in males. A multicentre international study. Moi H, Morel P, Gianotti B, Barlow D, Phillips I, Jean C. Drugs; 1995 Jan 06; 49 Suppl 2():387-9. PubMed ID: 8549371 [No Abstract] [Full Text] [Related]
32. Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin. Bowie WR, Willetts V, Jewesson PJ. Antimicrob Agents Chemother; 1989 Oct 06; 33(10):1778-82. PubMed ID: 2511802 [Abstract] [Full Text] [Related]
33. [A clinical study of lomefloxacin on the patients with urinary tract infections--focused on lomefloxacin-induced photosensitivity reaction]. Tozawa K, Washida H, Honma H, Kang K, Yamada Y. Hinyokika Kiyo; 1993 Sep 06; 39(9):801-5. PubMed ID: 8213373 [Abstract] [Full Text] [Related]
36. [The serum bactericidal activity of domestic fleroxacin and lomefloxacin]. Zhao M, Jiang S, Wang R. Zhonghua Nei Ke Za Zhi; 1999 Feb 06; 38(2):98-100. PubMed ID: 11798634 [Abstract] [Full Text] [Related]
37. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis). Hummler H, Richter WF, Hendrickx AG. Toxicol Appl Pharmacol; 1993 Sep 06; 122(1):34-45. PubMed ID: 8397453 [Abstract] [Full Text] [Related]
39. High-performance liquid chromatography for the determination of three new fluoroquinolones, fleroxacin, temafloxacin and A-64730, in biological fluids. Koechlin C, Jehl F, Linger L, Monteil H. J Chromatogr; 1989 Jul 21; 491(2):379-87. PubMed ID: 2509509 [Abstract] [Full Text] [Related]
40. Photocleavage of DNA by the fluoroquinolone antibacterials. Martínez L, Chignell CF. J Photochem Photobiol B; 1998 Aug 21; 45(1):51-9. PubMed ID: 9819899 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]